Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

JCENuveen Core Equity Alpha Fund

NYSE · CIK 0001385763
Filer category—
Entity typeother
SIC—
FY end—
XBRL facts0

Identity from submissions API

NameNuveen Core Equity Alpha Fund
CIK0001385763
TickersJCE
ExchangesNYSE
Entity typeother
Category—
SIC—
EIN000000000
LEI—
Fiscal year end—
State of incorporationMA MA
Phone312-917-8146
Website—
Investor website—
Owner org—
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
333 WEST WACKER DRIVE
CHICAGO
IL
60606
IL
Mailing address
333 WEST WACKER DRIVE
CHICAGO
IL
60606
IL

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

404 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-10-02 424B3 PROSPECTUS FILED PURSUANT TO RULE 424(B)(3) 0001999371-26-021914 333-279509 261433761 33 4354
2026-09-03 N-CSRS NUVEEN CORE EQUITY ALPHA FUND 0001193125-26-381215 811-22003 261356920 40 2979601
2026-09-01 3 xslF345X06/doc3.xml 0001225208-26-007453 6349
2026-08-27 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001385763-26-000016 811-22003 261325631 40 143069
2026-08-20 N-PX xslN-PX_X01/primary_doc.xml 0000930413-26-002602 811-22003 261297450 40 1333849
2026-07-30 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001445546-26-005563 005-85906 261221536 34 15320
2026-07-16 40-17G 40-17G 0001193125-26-305551 811-22003 261178955 40 551029
2026-05-28 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001385763-26-000010 811-22003 261028714 40 539894
2026-03-16 N-CEN xslFormN-CEN_X01/primary_doc.xml 0001193125-26-108229 811-22003 26756366 40 104039
2026-03-06 N-CSR NUVEEN CORE EQUITY ALPHA FUND 0001193125-26-096158 811-22003 26730199 40 5901219 1 1
2026-03-03 DEF 14A NUVEEN CORE EQUITY ALPHA FUND 0001193125-26-088806 811-22003 26716682 34 975282
2026-02-26 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001385763-26-000004 811-22003 26680776 40 116058
2026-02-23 3 xslF345X02/doc3.xml 0001225208-26-002334 6280
2025-11-26 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001385763-25-000007 811-22003 251525453 40 331915
2025-10-29 3 xslF345X02/doc3.xml 0001225208-25-008795 6262
2025-09-05 N-CSRS NUVEEN CORE EQUITY ALPHA FUND 0001193125-25-196748 811-22003 251295321 40 2649976
2025-08-27 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001752724-25-207141 811-22003 251260796 40 129204
2025-08-22 N-PX xslN-PX_X01/primary_doc.xml 0000930413-25-002664 811-22003 251245531 40 1220797
2025-07-31 40-17G 40-17G 0001193125-25-170182 811-22003 251169753 40 553739
2025-07-08 3 xslF345X02/doc3.xml 0001225208-25-006606 6172
2025-05-30 424B3 PROSPECTUS 0001999371-25-006889 333-279509 251006476 33 12537
2025-05-28 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001752724-25-123181 811-22003 25991711 40 486188
2025-03-17 N-CEN xslFormN-CEN_X01/primary_doc.xml 0001145549-25-018157 811-22003 25743405 40 234606
2025-03-07 N-CSR NUVEEN CORE EQUITY ALPHA FUND 0001193125-25-049470 811-22003 25718814 40 5822866 1 1
2025-03-04 DEF 14A NUVEEN CORE EQUITY ALPHA FUND 0001193125-25-045702 811-22003 25706255 34 1735223
2025-02-28 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001752724-25-046661 811-22003 25684508 40 125322
2024-12-03 3 xslF345X02/doc3.xml 0001225208-24-010355 5300
2024-11-26 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001752724-24-269078 811-22003 241498709 40 476352
2024-09-10 40-17G 40-17G 0001193125-24-216441 811-22003 241289431 40 533074
2024-09-05 N-CSRS NUVEEN CORE EQUITY ALPHA FUND 0001193125-24-214110 811-22003 241281073 40 7949756
2024-08-29 N-PX xslN-PX_X01/primary_doc.xml 0000930413-24-002597 811-22003 241258208 40 1390251
2024-08-27 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001752724-24-192481 811-22003 241243688 40 121830
2024-07-25 SC 13G SCHEDULE 13G 0001445546-24-005165 005-85906 241140250 34 16302
2024-07-19 EFFECT xslEFFECTX01/primary_doc.xml N-2,,2024-07-19 13:00:00 9999999995-24-002204 333-279509 241129132 33 1614
2024-07-19 424B2 PROSPECTUS 0001999371-24-008846 333-279509 241128047 33 1097259 1 1
2024-07-17 N-2/A AMENDMENT TO FORM N-2 0001999371-24-008740 811-22003,333-279509 241123912,241123911 40,33 2068404 1 1
2024-07-12 CORRESP filename1.htm 0001999371-24-008572 28486
2024-05-31 N-PX/A NUVEEN CORE EQUITY ALPHA FUND 0001193125-24-150941 811-22003 241007595 40 557303
2024-05-28 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001752724-24-124175 811-22003 24992852 40 511606
2024-05-17 N-2 INITIAL FILING OF A REGISTRATION STATEMENT 0001999371-24-006279 811-22003,333-279509 24960575,24960574 40,33 1390159
2024-05-17 N-PX/A NUVEEN CORE EQUITY ALPHA FUND 0001193125-24-141103 811-22003 24957649 40 557457
2024-03-15 N-CEN xslFormN-CEN_X01/primary_doc.xml 0001145549-24-016387 811-22003 24753172 40 94855
2024-03-11 3 xslF345X02/doc3.xml 0001225208-24-004017 5272
2024-03-08 3 xslF345X02/doc3.xml 0001225208-24-003940 5272
2024-03-07 N-CSR NUVEEN CORE EQUITY ALPHA FUND 0001193125-24-062336 811-22003 24731291 40 5696890 1 1
2024-03-06 8-K NUVEEN CORE EQUITY ALPHA FUND 7.01,9.01 0001193125-24-060628 811-22003 24725526 34 203265
2024-02-28 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001752724-24-045345 811-22003 24692006 40 122697
2024-02-27 DEF 14A NUVEEN CORE EQUITY ALPHA FUND 0001193125-24-047867 811-22003 24686213 34 731247
2024-01-31 SC 13G/A AMENDED SCHEDULE 13G 0001445546-24-000750 005-85906 24581026 34 16324
2024-01-11 3 xslF345X02/doc3.xml 0001225208-24-000837 7298
2024-01-09 3 xslF345X02/doc3.xml 0001225208-24-000650 7209
2024-01-09 3 xslF345X02/doc3.xml 0001225208-24-000649 7490
2024-01-09 3 xslF345X02/doc3.xml 0001225208-24-000648 7356
2023-12-01 40-17G 40-17G 0001193125-23-287139 811-22003 231458486 40 586146
2023-11-28 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001752724-23-270717 811-22003 231444848 40 523594
2023-10-13 8-K NUVEEN CORE EQUITY ALPHA FUND 5.02 0001193125-23-255632 811-22003 231323850 34 21282
2023-09-06 N-CSRS NUVEEN CORE EQUITY ALPHA FUND 0001193125-23-229247 811-22003 231238052 40 8661402
2023-08-28 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001752724-23-195350 811-22003 231214461 40 126395
2023-08-21 N-PX NUVEEN CORE EQUITY ALPHA FUND 0001193125-23-216409 811-22003 231187209 40 6770
2023-05-26 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001752724-23-121302 811-22003 23966371 40 607969
2023-05-09 CORRESP filename1.htm 0001193125-23-139118 72747
2023-03-30 DEF 14A NUVEEN CORE EQUITY ALPHA FUND 0001193125-23-084793 811-22003 23777805 34 844458
2023-03-16 N-CEN xslFormN-CEN_X01/primary_doc.xml 0001145549-23-016648 811-22003 23737362 40 144311
2023-03-09 N-CSR NUVEEN CORE EQUITY ALPHA FUND 0001193125-23-065801 811-22003 23718992 40 4396491
2023-02-28 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001752724-23-043900 811-22003 23677774 40 140107
2023-01-23 SC 13G/A AMENDED SCHEDULE 13G 0001445546-23-000334 005-85906 23542766 34 16269
2022-12-09 SC 13G/A AMENDED SCHEDULE 13G 0001445546-22-008398 005-85906 221453848 34 16270
2022-11-25 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001752724-22-265901 811-22003 221418070 40 576047
2022-11-02 40-17G 40-17G 0001193125-22-275513 811-22003 221352577 40 597409
2022-09-06 N-CSRS NUVEEN CORE EQUITY ALPHA FUND 0001193125-22-239004 811-22003 221228877 40 3418033
2022-08-26 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001752724-22-197914 811-22003 221205067 40 133312
2022-08-22 N-PX NUVEEN CORE EQUITY ALPHA FUND 0001193125-22-225830 811-22003 221182109 40 6733
2022-08-15 3 xslF345X02/doc3.xml 0001225208-22-009493 5216
2022-06-10 SC 13G/A AMENDED SCHEDULE 13G 0001445546-22-003990 005-85906 221007893 34 15779
2022-06-06 3 xslF345X02/doc3.xml 0001225208-22-007782 5203
2022-05-27 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001752724-22-127742 811-22003 22975906 40 596466
2022-04-21 3 xslF345X02/doc3.xml 0001225208-22-005954 2689
2022-03-16 N-CEN xslFormN-CEN_X01/primary_doc.xml 0001145549-22-016235 811-22003 22743653 40 110271
2022-03-09 N-CSR NUVEEN CORE EQUITY ALPHA FUND 0001193125-22-070645 811-22003 22725927 40 4247193
2022-02-25 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001752724-22-048080 811-22003 22679621 40 147545
2022-02-25 8-K 8-K 7.01,9.01 0001193125-22-053096 811-22003 22674242 34 46117
2022-02-24 DEF 14A NUVEEN CORE EQUITY ALPHA FUND 0001193125-22-052279 811-22003 22672016 34 1353305
2022-01-21 SC 13G/A AMENDED SCHEDULE 13G 0001445546-22-000408 005-85906 22544708 34 15786
2021-11-24 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001752724-21-258184 811-22003 211446316 40 614453
2021-09-24 40-17G 40-17G 0001193125-21-281891 811-22003 211276149 40 601570
2021-09-02 N-CSRS NUVEEN CORE EQUITY ALPHA FUND 0001193125-21-264191 811-22003 211232361 40 3198136
2021-08-26 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001752724-21-187304 811-22003 211211819 40 163938
2021-08-16 N-PX NUVEEN CORE EQUITY ALPHA FUND 0001193125-21-246763 811-22003 211174276 40 143637
2021-08-05 SC 13G/A SCHEDULE 13G/A 0000891092-21-005923 005-85906 211146996 34 13151
2021-07-07 3 xslF345X02/doc3.xml 0001225208-21-010365 5213
2021-07-07 3 xslF345X02/doc3.xml 0001225208-21-010364 5245
2021-05-27 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001752724-21-114896 811-22003 21969497 40 722516
2021-04-09 CORRESP filename1.htm 0001193125-21-111261 233036
2021-03-16 N-CEN xslFormN-CEN_X01/primary_doc.xml 0001145549-21-016281 811-22003 21744343 40 517382
2021-03-08 N-CSR NUVEEN CORE EQUITY ALPHA FUND 0001193125-21-072419 811-22003 21720793 40 1211271
2021-03-04 DEF 14A NUVEEN CORE EQUITY ALPHA FUND 0001193125-21-069085 811-22003 21713246 34 1692706
2021-02-26 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001752724-21-041932 811-22003 21683930 40 166023
2021-02-04 SC 13G/A SCHEDULE 13G/A 0000891092-21-000859 005-85906 21589977 34 12865
2021-02-03 SC 13G/A AMENDED SCHEDULE 13G 0001445546-21-000717 005-85906 21584737 34 15786
2020-11-27 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001752724-20-249760 811-22003 201352503 40 894383
2020-11-23 3 xslF345X02/doc3.xml 0001225208-20-013813 5758
2020-11-02 3 xslF345X02/doc3.xml 0001225208-20-012908 5756
2020-11-02 3 xslF345X02/doc3.xml 0001225208-20-012907 5778
2020-10-26 8-K NUVEEN CORE EQUITY ALPHA FUND 8.01,9.01 0001193125-20-275649 811-22003 201258682 34 27866
2020-10-13 40-17G 40-17G 0001193125-20-268191 811-22003 201235531 40 627743
2020-10-06 8-K 8-K 7.01,9.01 0001193125-20-264178 811-22003 201225216 34 304732
2020-10-02 DEFA14A NUVEEN CORE EQUITY ALPHA FUND 0001193125-20-262229 811-22003 201219023 34 24762
2020-09-14 DEFA14A NUVEEN CORE EQUITY ALPHA FUND 0001193125-20-245043 811-22003 201172988 34 35912
2020-09-09 SC 13G/A FORM SC 13G/A 0000891092-20-010314 005-85906 201167171 34 12809
2020-09-04 N-CSRS NUVEEN CORE EQUITY ALPHA FUND 0001193125-20-239727 811-22003 201161095 40 1098227
2020-08-27 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001752724-20-175493 811-22003 201140329 40 247336
2020-08-24 N-PX NUVEEN CORE EQUITY ALPHA FUND 0001193125-20-227509 811-22003 201124577 40 958902
2020-08-14 497 NUVEEN CORE EQUITY ALPHA FUND 0001193125-20-219881 333-228049 201102314 33 10069
2020-08-10 DEF 14A NUVEEN CORE EQUITY ALPHA FUND 0001193125-20-214379 811-22003 201088126 34 822059
2020-08-06 CORRESP filename1.htm 0001193125-20-211739 25262
2020-08-03 POS EX NUVEEN CORE EQUITY ALPHA FUND 0001193125-20-208033 333-228049 201069244 33 197178
2020-08-03 497 NUVEEN CORE EQUITY ALPHA FUND 0001193125-20-208028 333-228049 201069226 33 9474
2020-07-21 PRE 14A NUVEEN CORE EQUITY ALPHA FUND 0001193125-20-196207 811-22003 201038617 34 670662
2020-07-10 SC 13G/A FORM SC 13G/A 0000891092-20-008666 005-85906 201022716 34 12832
2020-06-26 497 NUVEEN CORE EQUITY ALPHA FUND 0001193125-20-181056 333-228049 20994650 33 3563
2020-05-28 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001752724-20-108283 811-22003 20921305 40 773939
2020-05-08 SC 13G FORM SC 13G 0000891092-20-006361 005-85906 20860094 34 12801
2020-04-02 DEFA14A NUVEEN CORE EQUITY ALPHA FUND 0001193125-20-096078 811-22003 20769677 34 29827
2020-03-25 497 NUVEEN CORE EQUITY ALPHA FUND 0001193125-20-084093 333-228049 20739606 33 14893
2020-03-16 N-CEN xslFormN-CEN_X01/primary_doc.xml 0001145549-20-015402 811-22003 20715789 40 182320
2020-03-06 3 xslF345X02/doc3.xml 0001225208-20-004614 5789
2020-03-06 N-CSR NUVEEN CORE EQUITY ALPHA FUND 0001193125-20-064809 811-22003 20694019 40 1255230
2020-03-02 DEF 14A NUVEEN CORE EQUITY ALPHA FUND 0001193125-20-059076 811-22003 20677632 34 1784487
2020-02-28 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001752724-20-041988 811-22003 20667017 40 297128
2020-02-12 SC 13G/A AMENDED SCHEDULE 13G 0001445546-20-000822 005-85906 20601016 34 16036
2019-12-02 497 NUVEEN CORE EQUITY ALPHA FUND 0001193125-19-304304 333-228049 191263370 33 2371071
2019-11-27 NPORT-P xslFormNPORT-P_X01/primary_doc.xml 0001752724-19-182301 811-22003 191255431 40 991161
2019-11-25 486BPOS NUVEEN CORE EQUITY ALPHA FUND 0001193125-19-300021 811-22003,333-228049 191247011,191247012 40,33 2872960
2019-10-28 40-17G 40-17G 0001193125-19-275859 811-22003 191172069 40 653563
2019-10-17 3 xslF345X02/doc3.xml 0001225208-19-013539 5768
2019-09-05 N-CSRS NUVEEN CORE EQUITY ALPHA FUND 0001193125-19-238628 811-22003 191076786 40 1029987
2019-08-19 N-PX NUVEEN CORE EQUITY ALPHA FUND 0001193125-19-223951 811-22003 191034827 40 943460
2019-08-16 3 xslF345X02/doc3.xml 0001225208-19-011500 5844
2019-08-16 3 xslF345X02/doc3.xml 0001225208-19-011499 5815
2019-07-10 SC 13G/A SCHEDULE 13G AMENDED 0000891092-19-007647 005-85906 19949774 34 13360
2019-05-30 NPORT-EX JCE.htm 0001752724-19-050717 811-22003 19864780 40 617698
2019-04-18 3 xslF345X02/doc3.xml 0001225208-19-006967 5798
2019-03-13 N-CEN xslFormN-CEN_X01/primary_doc.xml 0001145549-19-006838 811-22003 19677805 40 107300
2019-03-01 497 NUVEEN CORE EQUITY ALPHA FUND 0001193125-19-060942 333-228049 19649467 33 1137921
2019-03-01 N-CSR NUVEEN CORE EQUITY ALPHA FUND 0001193125-19-060742 811-22003 19648974 40 1174269
2019-02-26 DEF 14A NUVEEN CORE EQUITY ALPHA FUND 0001193125-19-051431 811-22003 19632403 34 1892973
2019-02-25 EFFECT xslEFFECTX01/primary_doc.xml N-2,,2019-02-25 12:30:00 9999999995-19-000321 333-228049 19631502 33 1580
2019-02-25 CORRESP filename1.htm 0001193125-19-049634 18064
2019-02-20 CORRESP filename1.htm 0001193125-19-045227 7211
2019-02-20 N-2/A NUVEEN CORE EQUITY ALPHA FUND 0001193125-19-045224 811-22003,333-228049 19617929,19617928 40,33 2601236
2019-02-20 CORRESP filename1.htm 0001193125-19-045222 22997
2019-02-11 SC 13G/A SCHEDULE 13G AMENDED 0000891092-19-001659 005-85906 19584059 34 11088
2019-02-11 SC 13G/A AMENDED SCHEDULE 13G 0001445546-19-000797 005-85906 19582779 34 16036
2019-01-31 CORRESP filename1.htm 0001193125-19-023835 30190
2018-11-29 N-Q NUVEEN CORE EQUITY ALPHA FUND 0001193125-18-337881 811-22003 181208209 40 594033
2018-10-30 N-2 NUVEEN CORE EQUITY ALPHA FUND 0001193125-18-311508 811-22003,333-228049 181145901,181145902 40,33 3142456
2018-09-06 N-CSRS NUVEEN CORE EQUITY ALPHA FUND 0001193125-18-267991 811-22003 181057161 40 1027770
2018-09-05 40-17G 40-17G 0001193125-18-267298 811-22003 181055886 40 645861
2018-08-20 N-PX NUVEEN CORE EQUITY ALPHA FUND 0001193125-18-252291 811-22003 181027037 40 793939
2018-08-15 3 xslF345X02/doc3.xml 0001225208-18-012634 5784
2018-08-15 3 xslF345X02/doc3.xml 0001225208-18-012606 5777
2018-05-30 N-Q NUVEEN CORE EQUITY ALPHA FUND 0001193125-18-178003 811-22003 18867175 40 584266
2018-03-08 N-CSR NUVEEN CORE EQUITY ALPHA FUND 0001193125-18-075143 811-22003 18676572 40 1132972
2018-03-01 NSAR-B jce1217answer.fil 0001083839-18-000030 811-22003 18657627 40 14407
2018-02-28 3 xslF345X02/doc3.xml 0001225208-18-004684 2715
2018-02-28 3 xslF345X02/doc3.xml 0001225208-18-004683 5783
2018-02-23 DEF 14A NUVEEN CORE EQUITY ALPHA FUND 0001193125-18-056125 811-22003 18637513 34 2308991
2018-02-01 SC 13G SCHEDULE 13G 0001013228-18-000155 005-85906 18565523 34 11177
2018-01-12 SC 13G/A AMENDED SCHEDULE 13G 0001445546-18-000181 005-85906 18524926 34 15977
2017-11-29 N-Q NUVEEN CORE EQUITY ALPHA FUND 0001193125-17-355200 811-22003 171227386 40 551967
2017-09-08 40-17G 40-17G 0001193125-17-280407 811-22003 171076198 40 725699
2017-09-07 N-CSRS NUVEEN CORE EQUITY ALPHA FUND 0001193125-17-279045 811-22003 171073615 40 967508
2017-08-29 NSAR-A jce0617answer.fil 0001083839-17-000159 811-22003 171058106 40 10826
2017-08-29 N-PX NUVEEN CORE EQUITY ALPHA FUND 0001193125-17-271062 811-22003 171056086 40 4294471
2017-08-10 3 xslF345X02/doc3.xml 0001225208-17-013726 6371
2017-08-10 3 xslF345X02/doc3.xml 0001225208-17-013666 5767
2017-08-08 3 xslF345X02/doc3.xml 0001225208-17-013394 5776
2017-08-08 3 xslF345X02/doc3.xml 0001225208-17-013390 5814
2017-07-10 3 xslF345X02/doc3.xml 0001225208-17-012484 5861
2017-05-30 N-Q NUVEEN CORE EQUITY ALPHA FUND 0001193125-17-186817 811-22003 17876331 40 460168
2017-04-27 DEFA14A NUVEEN CORE EQUITY ALPHA FUND 0001193125-17-143104 811-22003 17789537 34 22691
2017-04-17 4 xslF345X03/doc4.xml 0001225208-17-008089 4417
2017-04-12 144 144 0001193125-17-121419 811-22003 17758292 33 58034
2017-04-10 DEF 14A NUVEEN CORE EQUITY ALPHA FUND 0001193125-17-117953 811-22003 17752904 34 474459
2017-04-07 CORRESP filename1.htm 0001193125-17-116549 54981
2017-03-22 CORRESP filename1.htm 0001193125-17-092442 20404
2017-03-22 PRE 14A NUVEEN CORE EQUITY ALPHA FUND 0001193125-17-092252 811-22003 17707342 34 474181
2017-03-09 N-CSR NUVEEN CORE EQUITY ALPHA FUND 0001193125-17-076577 811-22003 17677960 40 1127624
2017-03-01 NSAR-B jce1216answer.fil 0001083839-17-000036 811-22003 17655153 40 14375
2017-01-11 SC 13G/A AMENDED SCHEDULE 13G 0001445546-17-000108 005-85906 17522237 34 15976
2016-11-29 N-Q NUVEEN CORE EQUITY ALPHA FUND 0001193125-16-779435 811-22003 162022409 40 512693
2016-10-11 3 xslF345X02/doc3.xml 0001225208-16-040329 2724
2016-09-30 40-APP/A EXEMPTION APPLICATION 0001193125-16-726844 812-14619-21 161911613 40 258760
2016-09-07 N-CSRS NUVEEN CORE EQUITY ALPHA FUND 0001193125-16-703034 811-22003 161872940 40 997486
2016-08-31 40-17G 40-17G 0001193125-16-698042 811-22003 161862762 40 652450
2016-08-29 NSAR-A jce0616answer.fil 0001083839-16-000414 811-22003 161858748 40 9216
2016-08-29 N-PX NUVEEN CORE EQUITY ALPHA FUND 0001193125-16-694555 811-22003 161856088 40 544884
2016-07-08 3 xslF345X02/doc3.xml 0001225208-16-036608 5781
2016-07-01 40-APP/A EXEMPTION APPLICATION 0001193125-16-640396 812-14619-21 161746612 40 263166
2016-06-24 3 xslF345X02/doc3.xml 0001225208-16-035594 5798
2016-05-27 N-Q NUVEEN CORE EQUITY ALPHA FUND 0001193125-16-605564 811-22003 161680621 40 382070 1
2016-03-10 DEF 14A NUVEEN CORE EQUITY ALPHA FUND 0001193125-16-500089 811-22003 161497769 34 1467581
2016-03-09 N-CSR NUVEEN CORE EQUITY ALPHA FUND 0001193125-16-498414 811-22003 161494654 40 1015582
2016-02-29 NSAR-B jce1215answer.fil 0001083839-16-000298 811-22003 161467759 40 14083
2016-02-24 3 xslF345X02/doc3.xml 0001225208-16-027814 5808
2016-02-23 40-APP EXEMPTION APPLICATION 0001193125-16-473827 812-14619-21 161449460 40 249197
2016-01-15 SC 13G/A AMENDED SCHEDULE 13G - FINAL 0001013228-16-003140 005-85906 161344981 34 11170
2016-01-11 SC 13G/A AMENDED SCHEDULE 13G 0001445546-16-006069 005-85906 161335496 34 16243
2015-11-27 N-Q NUVEEN CORE EQUITY ALPHA FUND 0001193125-15-389316 811-22003 151257388 40 363865
2015-10-22 40-APP/A EXEMPTION APPLICATION 0001193125-15-350898 812-14258-68 151171048 40 275948
2015-09-08 N-CSRS NUVEEN CORE EQUITY ALPHA FUND 0001193125-15-314124 811-22003 151096277 40 885860
2015-08-31 NSAR-A jce0615answer.fil 0001083839-15-000171 811-22003 151084976 40 9219
2015-08-28 40-17G 40-17G 0001193125-15-306710 811-22003 151081996 40 699195
2015-08-14 3 xslF345X02/doc3.xml 0001225208-15-017019 5857
2015-08-13 N-PX NUVEEN CORE EQUITY ALPHA FUND 0001193125-15-288959 811-22003 151048629 40 3765768
2015-07-21 CORRESP filename1.htm 0001193125-15-257870 228292
2015-05-29 N-Q N-Q 0001104659-15-041874 811-22003 15897941 40 697727
2015-05-22 40-APP/A EXEMPTION APPLICATION 0001193125-15-198023 812-14258-68 15884987 40 273873
2015-03-06 N-CSR N-CSR 0001104659-15-017746 811-22003 15682166 40 1334082
2015-03-05 3 xslF345X02/doc3.xml 0001225208-15-006862 5722
2015-03-02 NSAR-B jce1214answer.fil 0001083839-15-000035 811-22003 15664564 40 16304
2015-02-17 DEF 14A NUVEEN CORE EQUITY ALPHA FUND 0001258897-15-001416 811-22003 15624004 34 1389470
2015-02-11 SC 13G/A AMENDED SCHEDULE 13G 0001013228-15-000328 005-85906 15599122 34 10817
2015-02-06 SC 13G/A AMENDED SCHEDULE 13G 0001445546-15-000836 005-85906 15582820 34 15882
2014-12-08 40-APP/A EXEMPTION APPLICATION 0001193125-14-436255 812-14258-68 141272436 40 283287
2014-11-28 N-Q N-Q 0001104659-14-083848 811-22003 141255350 40 870867
2014-09-05 N-CSRS N-CSRS 0001104659-14-064873 811-22003 141084925 40 1265351
2014-08-29 NSAR-A jce0614answer.fil 0001083839-14-000170 811-22003 141075211 40 9196
2014-08-21 N-PX NUVEEN CORE EQUITY ALPHA FUND 0001193125-14-316357 811-22003 141056461 40 5448083
2014-08-14 40-17G 40-17G 0001193125-14-309920 811-22003 141041753 40 671329
2014-07-03 DEFA14A PRESS RELEASE 0001193125-14-260365 811-22003 14959339 34 39945
2014-07-01 40-APP/A EXEMPTION APPLICATION 0001193125-14-257621 812-14258-68 14952434 40 287159
2014-06-19 DEFA14A PRESS RELEASE 0001193125-14-242585 811-22003 14931087 34 107295
2014-06-19 DEF 14A CLOSED-END PROXY 0001193125-14-242583 811-22003 14931079 34 1199611
2014-06-18 DEFA14A PRESS RELEASE 0001193125-14-240780 811-22003 14927925 34 90632
2014-06-18 DEFA14A PRESS RELEASE 0001193125-14-240736 811-22003 14927791 34 83114
2014-05-30 N-Q N-Q 0001104659-14-042835 811-22003 14879472 40 881550
2014-05-19 PRE 14A CLOSED-END PROXY 0001193125-14-203147 811-22003 14852652 34 1215426
2014-05-01 DEFA14A PRESS RELEASE 0001193125-14-173934 811-22003 14801699 34 107038
2014-03-06 N-CSR N-CSR 0001104659-14-017067 811-22003 14673143 40 1478604
2014-03-03 NSAR-B jce1213answer.fil 0001083839-14-000030 811-22003 14659630 40 14455
2014-02-12 SC 13G SCHEDULE 13G 0001013228-14-000368 005-85906 14600910 34 10786
2014-02-06 SC 13G/A AMENDED SCHEDULE 13G 0001445546-14-000843 005-85906 14578371 34 15882
2013-12-27 40-APP EXEMPTION APPLICATION 0001193125-13-485931 812-14258-68 131300124 40 283392
2013-11-27 N-Q N-Q 0001104659-13-087395 811-22003 131246245 40 769975
2013-09-10 3 xslF345X02/doc3.xml 0001225208-13-019626 5803
2013-09-10 3 xslF345X02/doc3.xml 0001225208-13-019625 5772
2013-09-05 N-CSRS N-CSRS 0001104659-13-068172 811-22003 131080119 40 1438960
2013-08-29 NSAR-A jce063013answer.fil 0001083839-13-000204 811-22003 131067910 40 9165
2013-08-19 N-PX NUVEEN CORE EQUITY ALPHA FUND 0001193125-13-338812 811-22003 131046783 40 5819514
2013-08-09 40-17G 40-17G 0001193125-13-328941 811-22003 131026119 40 737610
2013-07-25 3 xslF345X02/doc3.xml 0001225208-13-016585 5789
2013-05-30 N-Q N-Q 0001104659-13-045746 811-22003 13881377 40 825910
2013-04-19 CORRESP filename1.htm 0001193125-13-162547 373044
2013-03-08 N-CSR N-CSR 0001104659-13-018781 811-22003 13676741 40 1695605
2013-03-01 NSAR-B jce12312012answer.fil 0001083839-13-000041 811-22003 13657405 40 14411
2013-02-28 DEF 14A NUVEEN CORE EQUITY ALPHA FUND 0001193125-13-082596 811-22003 13649713 34 1235666
2013-02-04 SC 13G/A AMENDED SCHEDULE 13G 0001445546-13-000717 005-85906 13568561 34 15854
2012-12-11 CORRESP filename1.htm 0001193125-12-498728 538289
2012-12-10 3 xslF345X02/doc3.xml 0001225208-12-024977 5803
2012-11-29 N-Q N-Q 0001104659-12-080815 811-22003 121231744 40 786523
2012-09-07 N-CSRS N-CSRS 0001104659-12-062239 811-22003 121079827 40 1309047
2012-08-29 NSAR-A answer.fil 0001083839-12-000262 811-22003 121063989 40 9497
2012-08-29 N-PX NUVEEN CORE EQUITY ALPHA FUND 0001193125-12-372786 811-22003 121061365 40 5189429
2012-08-16 40-17G 40-17G 0001193125-12-359018 811-22003 121039971 40 709343
2012-05-30 N-Q N-Q 0001104659-12-040716 811-22003 12877325 40 882470
2012-03-09 N-CSR N-CSR 0001104659-12-017130 811-22003 12681333 40 1719326
2012-03-01 DEF 14A FINAL PROXY DEF 14A 0001193125-12-092251 811-22003 12658141 34 1868130
2012-03-01 NSAR-B answer.fil 0001083839-12-000074 811-22003 12654665 40 13979
2012-02-17 CORRESP filename1.htm 0001193125-12-066840 56862
2012-02-02 PRE 14A NUVEEN CORE EQUITY ALPHA FUND 0001193125-12-037062 811-22003 12566885 34 1022416
2012-01-12 SC 13G/A AMENDED SCHEDULE 13G 0001445546-12-000148 005-85906 12523430 34 15707
2011-12-19 40-17G 40-17G 0001193125-11-345424 811-22003 111268842 40 714490
2011-11-29 N-Q N-Q 0001104659-11-066715 811-22003 111231854 40 745008
2011-09-08 SC 13G/A AMENDED SCHEDULE 13G 0001445546-11-003383 005-85906 111079858 34 15714
2011-09-07 N-CSRS N-CSRS 0001104659-11-050579 811-22003 111078937 40 1423698
2011-08-30 NSAR-A answer.fil 0001083839-11-000233 811-22003 111063814 40 36317
2011-08-26 N-PX NUVEEN CORE EQUITY ALPHA FUND 0001193125-11-233131 811-22003 111057761 40 4432534
2011-06-03 40-17G/A 40-17G/A 0000950123-11-056365 811-22003 11891294 40 112363
2011-05-27 N-Q N-Q 0000950123-11-055018 811-22003 11878544 40 404478
2011-04-08 SC 13G/A AMENDED SCHEDULE 13G 0001445546-11-001402 005-85906 11747917 34 15703
2011-03-30 DEF 14A DEF 14A 0000950123-11-030707 811-22003 11721550 34 1099091
2011-03-11 N-CSR FORM N-CSR 0000950123-11-024850 811-22003 11683017 40 1425603
2011-03-04 40-17G/A 40-17G/A 0000950123-11-022018 811-22003 11662948 40 111668
2011-03-02 NSAR-B answer.fil 0001083839-11-000035 811-22003 11653230 40 15012
2011-01-25 SC 13G SCHEDULE 13G 0001445546-11-000359 005-85906 11545757 34 16859
2011-01-12 3 xslF345X02/doc3.xml 0001225208-11-002655 6263
2011-01-12 3 xslF345X02/doc3.xml 0001225208-11-002654 6268
2010-12-23 4 xslF345X03/doc4.xml 0001225208-10-027732 4464
2010-12-16 40-17G/A 40-17G/A 0000950123-10-114212 811-22003 101256536 40 109454
2010-11-29 N-Q FORM N-Q 0000950123-10-109314 811-22003 101218974 40 335503
2010-11-04 40-17G/A 40-17G/A 0000950123-10-100674 811-22003 101163986 40 108903
2010-10-27 3 xslF345X02/doc3.xml 0001225208-10-023488 6387
2010-09-08 N-CSRS FORM N-CSR 0000950123-10-084564 811-22003 101062430 40 1222536
2010-08-30 NSAR-A answer.fil 0001083839-10-000147 811-22003 101046167 40 9932
2010-08-26 N-PX NUVEEN CORE EQUITY ALPHA FUND 0001193125-10-198230 811-22003 101040555 40 5406706
2010-08-05 3 xslF345X02/doc3.xml 0001225208-10-018553 6207
2010-06-04 40-17G/A 40-17G/A 0000950123-10-055826 811-22003 10878058 40 95504
2010-05-28 N-Q FORM N-Q 0000950123-10-054127 811-22003 10866040 40 417117
2010-05-06 40-17G/A 40-17G/A 0000950123-10-045341 811-22003 10806587 40 105154
2010-04-22 CORRESP filename1.htm 0001193125-10-089771 326977
2010-03-10 N-CSR FORM N-CSR 0000950123-10-023000 811-22003 10670201 40 2004903
2010-03-09 40-17G/A 40-17G/A 0000950123-10-022485 811-22003 10666669 40 93752
2010-02-26 NSAR-B answer.fil 0001083839-10-000046 811-22003 10638715 40 15147
2010-02-26 DEF 14A DEF 14A 0000950123-10-017406 811-22003 10636027 34 942026
2009-12-22 40-17G/A 40-17G/A 0000950123-09-072773 811-22003 091256063 40 93809
2009-12-09 40-17G/A FORM 40-17G/A 0000950123-09-069610 811-22003 091231798 40 95463
2009-11-27 3 xslF345X02/doc3.xml 0001225208-09-023200 6204
2009-11-27 N-Q N-Q 0000950123-09-066369 811-22003 091209144 40 453312
2009-09-08 N-CSRS N-CSRS 0000950123-09-041589 811-22003 091057805 40 1807885
2009-08-31 NSAR-A answer.fil 0001083839-09-000196 811-22003 091045875 40 9909
2009-08-26 N-PX NUVEEN CORE EQUITY ALPHA FUND 0001193125-09-181936 811-22003 091035517 40 2217632
2009-05-29 40-17G 40-17G 0000950137-09-004196 811-22003 09861656 40 92113
2009-05-29 N-Q FORM N-Q 0000950137-09-004188 811-22003 09861259 40 304621
2009-05-07 40-17G 40-17G 0000950137-09-003720 811-22003 09806791 40 92794
2009-04-02 DEF 14A DEFINITIVE PROXY STATEMENT 0000950137-09-002533 811-22003 09727327 34 1028411
2009-04-01 3/A xslF345X02/doc3a.xml 0001225208-09-009062 3313
2009-03-27 3 xslF345X02/doc3.xml 0001225208-09-008427 6180
2009-03-27 3 xslF345X02/doc3.xml 0001225208-09-008426 6152
2009-03-27 3 xslF345X02/doc3.xml 0001225208-09-008425 6173
2009-03-27 3 xslF345X02/doc3.xml 0001225208-09-008424 6183
2009-03-23 PRER14A PRER14A 0000950137-09-002138 811-22003 09698923 34 1039708
2009-03-09 N-CSR FORM N-CSR 0000950137-09-001653 811-22003 09667036 40 1729347
2009-03-03 40-17G FORM 40-17G 0000950137-09-001466 811-22003 09650629 40 89744
2009-03-02 PRE 14A PRELIMINARY PROXY STATEMENT 0000950137-09-001452 811-22003 09648389 34 1185834
2009-03-02 NSAR-B answer.fil 0001083839-09-000046 811-22003 09648265 40 14348
2009-01-13 40-17G 40-17G 0000950137-09-000266 811-22003 09524715 40 87595
2008-11-28 N-Q FORM N-Q 0000950152-08-009810 811-22003 081219122 40 366089
2008-09-08 N-CSRS NUVEEN CORE EQUITY ALPHA FUND N-CSRS 0000950137-08-011499 811-22003 081061408 40 1539592
2008-08-29 NSAR-A answer.fil 0001083839-08-000199 811-22003 081047267 40 9923
2008-08-28 N-PX NUVEEN CORE EQUITY ALPHA FUND 0001193125-08-186111 811-22003 081043418 40 2405948
2008-07-25 40-17G FORM 40-17G 0000950137-08-009650 811-22003 08969291 40 95312
2008-07-01 3 xslF345X02/tot308.xml 0001424228-08-000039 6336
2008-06-17 40-17G FORM 40-17G 0000950152-08-004657 811-22003 08903728 40 95814
2008-06-06 3 xslF345X02/roh307.xml 0001437043-08-000021 3204
2008-05-30 N-Q FORM N-Q 0000950137-08-008019 811-22003 08869401 40 413151
2008-05-16 DEF 14A DEFINITIVE PROXY STATEMENT 0000950137-08-007566 811-22003 08842153 34 1035770
2008-05-16 CORRESP filename1.htm 0000950137-08-007548 32803
2008-04-25 PRE 14A PRELIMINARY PROXY STATEMENT 0000950134-08-007509 811-22003 08778719 34 976861
2008-03-07 N-CSR FORM N-CSR 0000950137-08-003397 811-22003 08673328 40 258244
2008-02-29 NSAR-B answer.fil 0001083839-08-000056 811-22003 08654885 40 12105
2008-01-30 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0000950137-08-001412 811-22003 08561732 34 18928
2008-01-22 3 xslF345X02/win306.xml 0001390974-08-000012 3176
2008-01-09 40-17G FORM 40-17G 0000950137-08-000234 811-22003 08521422 40 89295
2007-11-29 N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS 0000950137-07-017965 811-22003 071274119 40 323190
2007-11-27 4 xslF345X02/zim305.xml 0001390974-07-000560 4740
2007-11-13 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0000950137-07-017088 811-22003 071238333 34 21341
2007-11-05 40-17G 40-17G 0000950137-07-016576 811-22003 071214404 40 87045
2007-10-15 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0000950137-07-015553 811-22003 071171613 34 18558
2007-10-12 40-17G FORM 40-17G 0000950137-07-015415 811-22003 071169053 40 85601
2007-09-06 N-CSRS N-CSRS - SEMI-ANNUAL REPORT 0000950137-07-013850 811-22003 071102230 40 212539
2007-09-05 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0000950137-07-013723 811-22003 071098007 34 25378
2007-08-30 N-PX NUVEEN CORE EQUITY ALPHA FUND 0001193125-07-192825 811-22003 071090799 40 361023
2007-08-29 NSAR-A answer.fil 0001083839-07-000198 811-22003 071088111 40 9368
2007-08-29 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0000950134-07-019203 811-22003 071086483 34 18047
2007-08-27 DEF 14A DEFINITIVE PROXY STATEMENT 0000950137-07-013088 811-22003 071081090 34 1426555
2007-08-14 DEFA14A SOLICITING MATERIAL 0000950124-07-004229 811-22003 071050342 34 30254
2007-08-10 PRE 14A PRELIMINARY PROXY STATEMENT 0000950137-07-012113 811-22003 071046327 34 1390513
2007-08-10 DEFA14A SOLICITING MATERIAL 0000950137-07-012066 811-22003 071045376 34 15478
2007-08-06 4 xslF345X02/amb304.xml 0001390974-07-000356 4763
2007-08-06 3 xslF345X02/amb303.xml 0001390974-07-000355 7149
2007-07-20 40-17G FORM 40-17G 0000950137-07-010245 811-22003 07990904 40 86035
2007-06-08 3 xslF345X02/ant301.xml 0001390974-07-000279 3212
2007-06-08 3 xslF345X02/ada302.xml 0001390974-07-000278 3169
2007-05-30 N-Q QUARTERLY REPORT 0000950137-07-008211 811-22003 07886483 40 340365
2007-05-15 40-17G FORM 40-17G 0000950137-07-007455 811-22003 07848379 40 83594
2007-05-15 40-17G FIDELITY BOND 0000950137-07-007454 811-22003 07848235 40 84534
2007-03-28 497 NUVEEN CORE EQUITY ALPHA FUND 0001193125-07-067247 333-139962 07724343 33 678539
2007-03-27 EFFECT xslEFFECTX01/primary_doc.xml N-2,,2007-03-27 11:15:00 9999999995-07-001038 333-139962 07722651 33 1992
2007-03-27 3 xslF345X02/zim300.xml 0001189642-07-000176 3163
2007-03-27 3 xslF345X02/sun299.xml 0001189642-07-000175 3154
2007-03-27 3 xslF345X02/sto298.xml 0001189642-07-000174 3096
2007-03-27 3 xslF345X02/sto297.xml 0001189642-07-000173 3143
2007-03-27 3 xslF345X02/sch296.xml 0001189642-07-000172 3160
2007-03-27 3 xslF345X02/sch295.xml 0001189642-07-000171 3141
2007-03-27 3 xslF345X02/run294.xml 0001189642-07-000170 3213
2007-03-27 3 xslF345X02/nuv293.xml 0001189642-07-000169 4047
2007-03-27 3 xslF345X02/mcc292.xml 0001189642-07-000168 3200
2007-03-27 3 xslF345X02/mar291.xml 0001189642-07-000167 3182
2007-03-27 3 xslF345X02/mag290.xml 0001189642-07-000166 3212
2007-03-27 3 xslF345X02/laz289.xml 0001189642-07-000165 3136
2007-03-27 3 xslF345X02/lam288.xml 0001189642-07-000164 3136
2007-03-27 3 xslF345X02/kun287.xml 0001189642-07-000163 3153
2007-03-27 3 xslF345X02/kel286.xml 0001189642-07-000162 3212
2007-03-27 3 xslF345X02/hur285.xml 0001189642-07-000161 3213
2007-03-27 3 xslF345X02/hun284.xml 0001189642-07-000160 3182
2007-03-27 3 xslF345X02/gut283.xml 0001189642-07-000159 3156
2007-03-27 3 xslF345X02/gam282.xml 0001189642-07-000158 3241
2007-03-27 3 xslF345X02/foy281.xml 0001189642-07-000157 3141
2007-03-27 3 xslF345X02/fer280.xml 0001189642-07-000156 3219
2007-03-27 3 xslF345X02/fer279.xml 0001189642-07-000155 3144
2007-03-27 3 xslF345X02/eva278.xml 0001189642-07-000154 3126
2007-03-27 3 xslF345X02/dro277.xml 0001189642-07-000153 3146
2007-03-27 3 xslF345X02/dar276.xml 0001189642-07-000152 3144
2007-03-27 3 xslF345X02/bro275.xml 0001189642-07-000151 3136
2007-03-27 3 xslF345X02/bre274.xml 0001189642-07-000150 3151
2007-03-27 3 xslF345X02/atk273.xml 0001189642-07-000149 3155
2007-03-27 3 xslF345X02/ant272.xml 0001189642-07-000148 3166
2007-03-26 N-2/A NUVEEN CORE EQUITY ALPHA FUND 0001193125-07-064370 811-22003,333-139962 07719044,07719043 40,33 2078348
2007-03-08 CERTNYS AUTO-GENERATED PAPER DOCUMENT 9999999997-07-010424 001-33324 07046340 34 1594

Latest XBRL company facts

One latest value per concept from companyfacts (0 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
No XBRL companyfacts for this CIK.

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →